Brief: Eurocine Vaccines Says Immunose Flu Showed Good Safety In Older Adults
Aug 8 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* NASAL INFLUENZA VACCINE CANDIDATE IMMUNOSE FLU SHOWED GOOD SAFETY IN OLDER ADULTS
* IMMUNOLOGICAL RESULTS ARE EXPECTED IN OCTOBER
Source text for Eikon: ID:nWkr2cQC8h
Further company coverage: EUCI.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate